Total Payments
$2,105
2023 Payments
$102.24
Companies
26
Transactions
124
Medicare Patients
1,685
Medicare Billing
$290,702
Payment Breakdown by Category
Food & Beverage$1,894 (90.0%)
Education$211.41 (10.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,894 | 116 | 90.0% |
| Education | $211.41 | 8 | 10.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $311.64 | 18 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $259.90 | 11 | $0 (2023) |
| Merck Sharp & Dohme LLC | $250.38 | 16 | $0 (2023) |
| Amgen Inc. | $197.02 | 16 | $0 (2020) |
| Astellas Pharma US Inc | $130.58 | 9 | $0 (2022) |
| Lilly USA, LLC | $128.22 | 10 | $0 (2022) |
| Genentech USA, Inc. | $98.45 | 6 | $0 (2022) |
| Clovis Oncology, Inc. | $95.00 | 1 | $0 (2019) |
| Seagen Inc. | $89.88 | 4 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $82.64 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $102.24 | 5 | Dendreon Pharmaceuticals LLC ($28.89) |
| 2022 | $329.60 | 21 | Astellas Pharma US Inc ($59.56) |
| 2021 | $413.38 | 25 | Novartis Pharmaceuticals Corporation ($63.23) |
| 2020 | $121.25 | 8 | Amgen Inc. ($32.50) |
| 2019 | $543.31 | 29 | E.R. Squibb & Sons, L.L.C. ($129.13) |
| 2018 | $383.68 | 25 | Merck Sharp & Dohme Corporation ($87.68) |
| 2017 | $211.77 | 11 | Novartis Pharmaceuticals Corporation ($68.08) |
All Payment Transactions
124 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2023 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $28.89 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 04/24/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $16.65 | General |
| Category: Hematology | ||||||
| 02/21/2023 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $13.53 | General |
| Category: Oncology | ||||||
| 01/30/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: ONCOLOGY | ||||||
| 01/25/2023 | G1 Therapeutics, Inc. | COSELA (Drug) | Food and Beverage | Cash or cash equivalent | $23.47 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Oncology | ||||||
| 11/15/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $20.79 | General |
| Category: Oncology | ||||||
| 10/17/2022 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Oncology | ||||||
| 09/19/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: ONCOLOGY | ||||||
| 09/13/2022 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: Oncology | ||||||
| 08/16/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $12.76 | General |
| Category: Oncology | ||||||
| 08/15/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Oncology | ||||||
| 08/03/2022 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Oncology | ||||||
| 07/19/2022 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: ONCOLOGY | ||||||
| 07/12/2022 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA, MEKINIST | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: ONCOLOGY | ||||||
| 06/27/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: ONCOLOGY | ||||||
| 06/14/2022 | Genentech USA, Inc. | VENCLEXTA (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: BioOncology | ||||||
| 06/14/2022 | Genentech USA, Inc. | VENCLEXTA (Biological) | Food and Beverage | In-kind items and services | $0.78 | General |
| Category: BioOncology | ||||||
| 06/06/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Oncology | ||||||
| 05/10/2022 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: Oncology | ||||||
| 04/28/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $13.97 | General |
| Category: Oncology | ||||||
| 04/05/2022 | Lilly USA, LLC | RETEVMO (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Oncology | ||||||
| 03/22/2022 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 03/15/2022 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: ONCOLOGY | ||||||
| 03/14/2022 | Celgene Corporation | ONUREG (Drug) | Food and Beverage | Cash or cash equivalent | $13.04 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 170 | 731 | $73,133 | $28,399 |
| 2022 | 16 | 425 | 1,891 | $181,687 | $72,019 |
| 2021 | 18 | 524 | 18,268 | $216,407 | $87,676 |
| 2020 | 18 | 566 | 20,271 | $300,298 | $102,608 |
Total Patients
1,685
Total Services
41,161
Medicare Billing
$290,702
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 323 | $67,184 | $26,804 | 39.9% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 14 | 45 | $2,610 | $943.40 | 36.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 41 | $1,968 | $381.96 | 19.4% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 11 | 12 | $1,284 | $239.40 | 18.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 11 | 310 | $86.80 | $30.48 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 168 | 431 | $89,648 | $38,615 | 43.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 27 | 152 | $38,456 | $14,957 | 38.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 27 | 27 | $10,881 | $4,169 | 38.3% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2022 | 12 | 55 | $6,435 | $2,669 | 41.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 14 | $5,600 | $2,158 | 38.5% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2022 | 18 | 80 | $4,640 | $1,785 | 38.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 34 | 39 | $5,499 | $1,655 | 30.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 18 | 29 | $3,770 | $1,416 | 37.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 18 | 109 | $5,232 | $1,112 | 21.3% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2022 | 15 | 48 | $2,208 | $759.91 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 12 | $2,016 | $742.20 | 36.8% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 13 | 59 | $2,478 | $698.49 | 28.2% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2022 | 12 | 27 | $2,889 | $669.24 | 23.2% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2022 | 12 | 51 | $1,479 | $486.72 | 32.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 13 | 730 | $204.40 | $70.03 | 34.3% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2022 | 13 | 28 | $252.00 | $55.22 | 21.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 153 | 356 | $74,048 | $33,525 | 45.3% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 26 | 151 | $38,203 | $16,036 | 42.0% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2021 | 13 | 15,750 | $31,500 | $14,171 | 45.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 78 | 99 | $13,959 | $6,589 | 47.2% |
About Dr. David Brown, MD
Dr. David Brown, MD is a Hematology & Oncology healthcare provider based in Toledo, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1710985361.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Brown, MD has received a total of $2,105 in payments from pharmaceutical and medical device companies, with $102.24 received in 2023. These payments were reported across 124 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($1,894).
As a Medicare-enrolled provider, Brown has provided services to 1,685 Medicare beneficiaries, totaling 41,161 services with total Medicare billing of $290,702. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Toledo, OH
- Active Since 07/08/2005
- Last Updated 01/31/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1710985361
Products in Payments
- KEYTRUDA (Biological) $231.12
- OPDIVO (Biological) $229.97
- LUTATHERA (Drug) $103.28
- XTANDI (Drug) $97.15
- Rubraca (Drug) $95.00
- PADCEV (Biological) $89.88
- Stivarga (Drug) $82.64
- VERZENIO (Drug) $77.84
- KISQALI (Drug) $68.92
- Xtandi (Drug) $59.56
- Neulasta (Biological) $59.31
- Cabometyx (Drug) $47.57
- Avastin (Biological) $43.94
- SANDOSTATIN LAR (Drug) $43.81
- RETEVMO (Drug) $39.38
- VOTRIENT (Drug) $34.34
- IBRANCE (Drug) $31.80
- PROMACTA (Drug) $31.71
- Kyprolis (Biological) $30.26
- PROVENGE (Drug) $28.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Toledo
Dr. Rex Mowat, Md, MD
Hematology & Oncology — Payments: $122,388
Hematology & Oncology $122,388
Ahmad Zarzour, M.d, M.D
Hematology & Oncology — Payments: $23,407
Hematology & Oncology $23,407
Dr. Mohammad Rashid, Md, MD
Hematology & Oncology — Payments: $1,985
Hematology & Oncology $1,985
Dr. Danae Hamouda, M.d, M.D
Hematology & Oncology — Payments: $1,239
Hematology & Oncology $1,239
Timothy Kasunic, Md, MD
Hematology & Oncology — Payments: $956.37
Hematology & Oncology $956.37
Abhay Shelke, Md, MD
Hematology & Oncology — Payments: $665.04
Hematology & Oncology $665.04